Table 2 Concurrent medications identified as having risk of QT prolongation and/or Torsades de Pointes

Amiodarone

Dofetilide

Levofloxacin

Quetiapine

Amisulpride

Dolasetron

Levomepromazine

Quinidine

Amitriptyline

Domperidone

Lithium

Ranolazine

Atazanavir

Erythromycin

Lopinavir/ritonavir

Risperidone

Azithromycin

Escitalopram

Maprotiline

Sevoflurane

Bedaquiline

Flecainide

Methadone

Sulpiride

Bendroflumethiazide

Fluconazole

Metoclopramide

Tacrolimus

Bepridil

Fluoxetine

Mianserin

Telithromycin

Betrixaban

Fluvoxamine

Mirtazapine

Thioridazin

Buprenorphine

Furosemide

Moxifloxacin

Tiapride

Chlorpromazine

Granisetron

Nicardipine

Tizanidine

Cimetidine

Haloperidol

Nortriptyline

Torasemide

Ciprofloxacin

Hydrochlorothiazide

Ofloxacin

Tramadol

Citalopram

Hydrocodone

Ondansetron

Trazodone

Clarithromycin

Hydroxyzine

Paloperidone

Trimipramine

Clofazimine

Iloperidone

Paroxetine

Venlafaxine

Clomipramine

Imipramine

Perphenazine

Voriconazole

Clozapine

Indapamide

Pimozide

Ziprasidone

Delamanid

Itraconazole

Posaconazole

Zotepine

Desipramine

Ivabradine

Prochlorperazine

Zuclopenthixol

Dexmedetomidine

Ketoconazole

Propafenone

Disopyramide

Lacidipine

Propofol